date:Nov 08, 2012
at information, Entis said. This is one of the things that can extend the duration of an outbreak.
While releasing confidential commercial information is a reason FDA would refuse to implicate a specific company during an outbreak, it is unlikely that FDA is afraid of any legal repercussions for prematurely implicating the wrong company, or inadvertently impacting the food industry at large.
Under U.S. Supreme Court precedent regarding federal administrative law (see Chrysler Corp. v. Brown,